The effect of secretory leukocyte protease inhibitor (SLPI) on ischemia/reperfusion injury in cardiac transplantation

American Journal of Transplantation

Volumn 8, Issue 4, 2008, Pages 773-782

  Schneeberger, S ^a   Hautz, T ^a   Wahl, S M ^b   Brandacher, G ^a   Sucher, R ^a   Steinmassl, O ^a   Steinmassl, P ^a   Wright, C D ^c,e   Obrist, P ^d   Werner, E R ^a   Mark, W ^a   Troppmair, J ^a   Margreiter, R ^a   Amberger, A ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^c AMGEN INC   (United States)

^d St Vinzenz Hospital Zams   (Austria)

^e GILEAD SCIENCES INC   (United States)

Author keywords

Heart transplantation; Ischemia; Reperfusion; SLPI

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PRESERVATION SOLUTION; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL VACUOLE; COLD ISCHEMIA; CONTROLLED STUDY; GENE EXPRESSION; HEART CONTRACTION; HEART FUNCTION; HEART GRAFT; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART TRANSPLANTATION; HISTOPATHOLOGY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEART TRANSPLANTATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL CONTRACTION; RECOMBINANT PROTEINS; REPERFUSION INJURY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, ISOGENEIC;

EID: 40449125598     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2008.02158.x     Document Type: Article

References (34)

1. Appleyard RF, Cohn LH. Myocardial stunning and reperfusion injury in cardiac surgery. J Card Surg 1993 8 : 316 324.
2. Fyfe B, Loh E, Winters GL, Couper GS, Kartashov AI, Schoen FJ. Heart transplantation-associated perioperative ischemic myocardial injury. Morphological features and clinical significance. Circulation 1996 93 : 1133 1140.
3. Taqueti VR, Mitchell RN, Lichtman AH. Protecting the pump: Controlling myocardial inflammatory responses. Annu Rev Physiol 2006 68 : 67 95.
4. Tanaka M, Mokhtari GK, Terry RD et al. Prolonged cold ischemia in rat cardiac allografts promotes ischemia-reperfusion injury and the development of graft coronary artery disease in a linear fashion. J Heart Lung Transplant 2005 24 : 1906 1914.
5. Knight RJ, Dikman S, Liu H, Martinelli GP. Cold ischemic injury accelerates the progression to chronic rejection in a rat cardiac allograft model. Transplantation 1997 64 : 1102 1107.
6. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 2002 53 : 31 47.
7. Zahler S, Massoudy P, Hartl H, Hahnel C, Meisner H, Becker BF. Acute cardiac inflammatory responses to postischemic reperfusion during cardiopulmonary bypass. Cardiovasc Res 1999 41 : 722 730.
8. Li D, Zhao L, Liu M et al. Kinetics of tumor necrosis factor alpha in plasma and the cardioprotective effect of a monoclonal antibody to tumor necrosis factor alpha in acute myocardial infarction. Am Heart J 1999 137 : 1145 1152.
9. Wahl SM, Costa GL, Corcoran M, Wahl LM, Berger AE. Transforming growth factor-beta mediates IL-1-dependent induction of IL-1 receptor antagonist. J Immunol 1993 150 : 3553 3560.
10. Tonnessen T, Florholmen G, Henriksen UL, Christensen G. Cardiopulmonary alterations in mRNA expression for interleukin-1beta, the interleukin-6 superfamily and CXC-chemokines during development of postischaemic heart failure in the rat. Clin Physiol Funct Imaging 2003 23 : 263 268.
11. Birdsall HH, Green DM, Trial J et al. Complement C5a, TGF-beta 1, and MCP-1, in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to five hours after reperfusion. Circulation 1997 95 : 684 692.
12. Aziz T, Saad RA, Burgess M, Yonan N, Hasleton P, Hutchinson IV. Transforming growth factor beta and myocardial dysfunction following heart transplantation. Eur J Cardiothorac Surg 2001 20 : 177 186.
13. Amberger A, Schneeberger S, Hernegger G et al. Gene expression profiling of prolonged cold ischemia and reperfusion in murine heart transplants. Transplantation 2002 74 : 1441 1449.
14. Schneeberger S, Brandacher G, Mark W, Amberger A, Margreiter R. Protease inhibitors as a potential target in modulation of postischemic inflammation. Drug News Perspect 2002 15 : 568 574.
15. Thompson RC, Ohlsson K. Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc Natl Acad Sci USA 1986 83 : 6692 6696.
16. Stetler G, Brewer MT, Thompson RC. Isolation and sequence of a human gene encoding a potent inhibitor of leukocyte proteases. Nucleic Acids Res 1986 14 : 7883 7896.
17. Jin FY, Nathan C, Radzioch D, Ding A. Secretory leukocyte protease inhibitor: A macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell 1997 88 : 417 426.
18. Song X, Zeng L, Jin W et al. Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis. J Exp Med 1999 190 : 535 542.
19. Ashcroft GS, Lei K, Jin W et al. Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing. Nat Med 2000 6 : 1147 1153.
20. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973 16 : 343 350.
21. Kuznetsov AV, Schneeberger S, Seiler R et al. Mitochondrial defects and heterogeneous cytochrome c release after cardiac cold ischemia and reperfusion. Am J Physiol Heart Circ Physiol 2004 286 : H1633 H1641.
22. Zitnik RJ, Zhang J, Kashem MA et al. The cloning and characterization of a murine secretory leukocyte protease inhibitor cDNA. Biochem Biophys Res Commun 1997 232 : 687 697.
23. Wright CD, Kennedy JA, Zitnik RJ, Kashem MA. Inhibition of murine neutrophil serine proteinases by human and murine secretory leukocyte protease inhibitor. Biochem Biophys Res Commun 1999 254 : 614 617.
24. Tiefenbacher CP, Ebert M, Niroomand F et al. Inhibition of elastase improves myocardial function after repetitive ischaemia and myocardial infarction in the rat heart. Pflugers Arch 1997 433 : 563 570.
25. Cowan B, Baron O, Crack J, Coulber C, Wilson GJ, Rabinovitch M. Elafin, a serine elastase inhibitor, attenuates post-cardiac transplant coronary arteriopathy and reduces myocardial necrosis in rabbits afer heterotopic cardiac transplantation. J Clin Invest 1996 97 : 2452 2468.
26. Ueno M, Moriyama Y, Toda R et al. Effect of a neutrophil elastase inhibitor (ONO-5046 Na) on ischemia/reperfusion injury using the left-sided heterotopic canine heart transplantation model. J Heart Lung Transplant 2001 20 : 889 896.
27. Hoffmeyer MR, Scalia R, Ross CR, Jones SP, Lefer DJ. PR-39, a potent neutrophil inhibitor, attenuates myocardial ischemia- reperfusion injury in mice. Am J Physiol Heart Circ Physiol 2000 279 : 2824 2828.
28. Lentsch AB, Yoshidome H, Warner RL, Ward PA, Edwards MJ. Secretory leukocyte protease inhibitor in mice regulates local and remote organ inflammatory injury induced by hepatic ischemia/reperfusion. Gastroenterology 1999 117 : 953 961.
29. Zimmerman BJ, Grange DN. Reperfusion-induced leukocyte infiltration: Role of elastase. Am J Physiol 1990 259 : 390 394.
30. Munger JS, Harpel JG, Gleizes PE, Mazzieri R, Nunes I, Rifkin DB. Latent transforming growth factor-beta: Structural features and mechanisms of activation. Kidney Int 1997 51 : 1376 1382.
31. Jaumann F, Elssner A, Mazur G, Dobmann S, Vogelmeier C. Transforming growth factor-beta1 is a potent inhibitor of secretory leukoprotease inhibitor expression in a bronchial epithelial cell line. Munich Lung Transplant Group. Eur Respir J 2000 15 : 1052 1057.
32. Ikeuchi M, Tsutsui H, Shiomi T et al. Inhibition of TGF-beta signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction. Cardiovasc Res 2004 64 : 526 535.
33. Gast A, Anderson W, Probst A et al. Pharmacokinetics and distribution of recombinant secretory leukocyte proteinase inhibitor in rats. Am Rev Resp Dis 1990. 141 (4 Pt 1 889 894.
34. Bergenfeldt M, Bjork P, Ohlsson K. The elimination of secretory leukocyte protease inhibitor (SLPI) after intravenous injection in dog and man. Scand J Clin Lab Invest 1990 50 : 729 737.